SpecGx LLC drugs

44 results

  • acetaminophen and codeine phosphate

    (acetaminophen and codeine phosphate)
    SpecGx LLC
    Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain when alternative treatments are inadequate. Use is limited due to risks of addiction, abuse, and misuse, and they should not be used long-term unless necessary.
    Medication Details
    Drug Interactions

  • amphetamine sulfate

    (Amphetamine Sulfate)
    SpecGx LLC
    Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity as part of a comprehensive treatment approach, and short-term management of exogenous obesity in patients not responding to other weight reduction therapies.
    Medication Details
    Drug Interactions

  • buprenorphine hydrochloride and naloxone hydrochloride dihydrate

    (Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate)
    SpecGx LLC
    Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, and should be used in conjunction with a comprehensive treatment plan that includes counseling and psychosocial support.
    Medication Details
    Drug Interactions

  • dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate

    (dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate)
    SpecGx LLC
    Mixed Salts of a Single Entity Amphetamine Product is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy, addressing symptoms that impair functioning in various settings and are present from a young age.
    Medication Details
    Drug Interactions

  • dextroamphetamine sulfate

    (dextroamphetamine sulfate)
    SpecGx LLC
    Dextroamphetamine sulfate extended-release capsules are indicated for the treatment of narcolepsy and Attention Deficit Disorder with Hyperactivity (ADHD) in children aged 6 to 16. It's part of a comprehensive treatment plan that includes psychological, educational, and social interventions.
    Medication Details
    Drug Interactions